Stem-cell-based therapies

BioProcess International

Volumn 9, Issue SUPPL. 1, 2011, Pages 20-25

  Shaw, Robert ^a  

^a Stem Cells/Cell Biology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; T LYMPHOCYTE RECEPTOR;

ACUTE HEART INFARCTION; ADIPOCYTE; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; BONE MATRIX; BRAIN ISCHEMIA; CANCER REGRESSION; CARTILAGE CELL; CELL DIFFERENTIATION; CYTOTOXICITY; DNA MODIFICATION; DRUG SCREENING; EMBRYONIC STEM CELL; GENETIC MANIPULATION; GLIOBLASTOMA; HEART STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOMODULATION; LARGE SCALE PRODUCTION; MELANOMA; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MULTIPOTENT STEM CELL; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; OLIGODENDROGLIA; OSTEOBLAST; PERSONALIZED MEDICINE; PLURIPOTENT STEM CELL; SHORT SURVEY; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REGENERATION;

EID: 79953067383     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Short Survey

References (13)

1. McKernan R, McNeish J, Smith D. Pharma's Developing Interest in Stem Cells. Cell Stem Cell 6, 2010: 517-520.
2. Ha SP, et al. Transplantation of Mouse HSCs Genetically Modified to Express a CD4-Restricted TCR Results in Long-Term Immunity that Destroys Tumors and Initiates Spontaneous Autoimmunity. J. Clin. Investigation 120(12) 2010: 4273-4288.
3. Psaltis PJ, et al. Concise Review: Mesenchymal Stromal Cells: Potential for Cardiovascular Repair. Stem Cells 26(9) 2008:2201-2210.
4. Doeppner TR, Hermann DM. Mesenchymal Stem Cells in the Treatment of Ischemic Stroke: Progress and Possibilities. Stem Cells Cloning 3, 2010: 157-163.
5. Martin-Rendon E, et al. Autologous Bone Marrow Stem Cells to Treat Acute Myocardial Infarction: A Systematic Review. Euro. Heart J. 29, 2008: 1807-1818.
6. Strauss S. Geron Trial Resumes but Standards for Stem Cell Trials Remain Elusive. Nature Biotechnol. 28, 2010: 989-899.
7. Takahashi K, Yamanaka S. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures By Defined Factors. Cell 126, 2006: 633-676.
8. Takahashi K, et al. Induction of Pluripotent Stem Sells from Adult Human Fibroblasts By Defined Factors. Cell 131(5) 2007: 834-835.
9. Baker M. Integration-Free iPS Cells. Nature Reports Stem Cells, 16 October 2008.
10. Sommer CA, et al. Excision of Reprogramming Transgenes Improves Differentiation Potential of iPS Cells Generated with a Single Excisable Vector. Stem Cells 28(1) 2010: 64-74.
11. Warren L, et al. Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA. Cell Stem Cell 2010: in press.
12. Cadwell K, et al. Virus Plus Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in Intestine. Cell 25 June 2010.
13. Shaw R. Industrializing Stem Cell Production. BioProcess Int. 8(9) 2010: 10-15.